StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$29.04+0.21 (+0.73%)

Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –

Supernus price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Supernus's price to sales ratio was 2.8× on Nov 11, 2026, against 3.6× a year earlier. Over the last 4 years it ranged from 1.0× to 4.7×, with a median of 2.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.8×−1.0
2025Dec 31, 20253.9×+2.3
2024Dec 31, 20241.6×−0.8
2023Dec 29, 20232.4×−1.8
2022Dec 30, 20224.2×–

More Supernus figures

See a number that looks wrong?